Literature DB >> 26062982

Concise Review: Manufacturing of Pancreatic Endoderm Cells for Clinical Trials in Type 1 Diabetes.

Thomas C Schulz1.   

Abstract

The cellular component of ViaCyte's VC-01 combination product for type 1 diabetes, pancreatic endoderm cells (PEC-01) derived from CyT49 human embryonic stem cells, matures after transplantation and functions to regulate blood glucose in rodent models. The aims in manufacturing PEC-01 at scale are to generate a consistent and robust transplantable population that functions reliably and safely in vivo. ViaCyte has integrated multiple bioprocessing strategies to enable a tightly controlled PEC-01 manufacturing process for clinical entry. ©AlphaMed Press.

Entities:  

Keywords:  Cell differentiation; Embryonic stem cells; Endoderm; Pancreas

Mesh:

Substances:

Year:  2015        PMID: 26062982      PMCID: PMC4511151          DOI: 10.5966/sctm.2015-0058

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  15 in total

Review 1.  Pancreatic islet cell transplantation: an update for interventional radiologists.

Authors:  Ron C Gaba; Raquel Garcia-Roca; Jose Oberholzer
Journal:  J Vasc Interv Radiol       Date:  2012-03-13       Impact factor: 3.464

2.  Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells.

Authors:  Olivia G Kelly; Man Yin Chan; Laura A Martinson; Kuniko Kadoya; Traci M Ostertag; Kelly G Ross; Mike Richardson; Melissa K Carpenter; Kevin A D'Amour; Evert Kroon; Mark Moorman; Emmanuel E Baetge; Anne G Bang
Journal:  Nat Biotechnol       Date:  2011-07-31       Impact factor: 54.908

3.  Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.

Authors:  Alireza Rezania; Jennifer E Bruin; Payal Arora; Allison Rubin; Irina Batushansky; Ali Asadi; Shannon O'Dwyer; Nina Quiskamp; Majid Mojibian; Tobias Albrecht; Yu Hsuan Carol Yang; James D Johnson; Timothy J Kieffer
Journal:  Nat Biotechnol       Date:  2014-09-11       Impact factor: 54.908

4.  Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape.

Authors:  Kaitlyn Kirk; Ergeng Hao; Reyhaneh Lahmy; Pamela Itkin-Ansari
Journal:  Stem Cell Res       Date:  2014-03-24       Impact factor: 2.020

5.  Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.

Authors:  Evert Kroon; Laura A Martinson; Kuniko Kadoya; Anne G Bang; Olivia G Kelly; Susan Eliazer; Holly Young; Mike Richardson; Nora G Smart; Justine Cunningham; Alan D Agulnick; Kevin A D'Amour; Melissa K Carpenter; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2008-02-20       Impact factor: 54.908

6.  Generation of functional human pancreatic β cells in vitro.

Authors:  Felicia W Pagliuca; Jeffrey R Millman; Mads Gürtler; Michael Segel; Alana Van Dervort; Jennifer Hyoje Ryu; Quinn P Peterson; Dale Greiner; Douglas A Melton
Journal:  Cell       Date:  2014-10-09       Impact factor: 41.582

7.  Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3.

Authors:  Barak Blum; Siniša Hrvatin; Christian Schuetz; Claire Bonal; Alireza Rezania; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2012-02-26       Impact factor: 54.908

8.  Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice.

Authors:  Alireza Rezania; Jennifer E Bruin; Michael J Riedel; Majid Mojibian; Ali Asadi; Jean Xu; Rebecca Gauvin; Kavitha Narayan; Francis Karanu; John J O'Neil; Ziliang Ao; Garth L Warnock; Timothy J Kieffer
Journal:  Diabetes       Date:  2012-06-27       Impact factor: 9.337

9.  Advances and challenges in islet transplantation: islet procurement rates and lessons learned from suboptimal islet transplantation.

Authors:  Annette Plesner; C Bruce Verchere
Journal:  J Transplant       Date:  2011-12-22

10.  Treatment of diabetic rats with encapsulated islets.

Authors:  Ian R Sweet; Ofer Yanay; Lanaya Waldron; Merle Gilbert; Jessica M Fuller; Terry Tupling; Ake Lernmark; William R A Osborne
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

View more
  27 in total

Review 1.  The Nexus of Stem Cell-Derived Beta-Cells and Genome Engineering.

Authors:  Sara D Sackett; Aida Rodriguez; Jon S Odorico
Journal:  Rev Diabet Stud       Date:  2017-06-12

2.  Utilizing FUCCI reporters to understand pluripotent stem cell biology.

Authors:  Amar M Singh; Robert Trost; Benjamin Boward; Stephen Dalton
Journal:  Methods       Date:  2015-09-21       Impact factor: 3.608

Review 3.  Manufacturing Cell Therapies Using Engineered Biomaterials.

Authors:  Amr A Abdeen; Krishanu Saha
Journal:  Trends Biotechnol       Date:  2017-07-12       Impact factor: 19.536

Review 4.  Pluripotent stem cells progressing to the clinic.

Authors:  Alan Trounson; Natalie D DeWitt
Journal:  Nat Rev Mol Cell Biol       Date:  2016-03       Impact factor: 94.444

5.  Glucocorticoid Signaling Enhances Expression of Glucose-Sensing Molecules in Immature Pancreatic Beta-Like Cells Derived from Murine Embryonic Stem Cells In Vitro.

Authors:  Nadiah Ghazalli; Xiaoxing Wu; Stephanie Walker; Nancy Trieu; Li-Yu Hsin; Justin Choe; Chialin Chen; Jasper Hsu; Jeanne LeBon; Mark T Kozlowski; Jeffrey Rawson; David A Tirrell; M L Richard Yip; Hsun Teresa Ku
Journal:  Stem Cells Dev       Date:  2018-06-06       Impact factor: 3.272

6.  How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation.

Authors:  John P A Ioannidis; Betty Y S Kim; Alan Trounson
Journal:  Nat Biomed Eng       Date:  2018-11-08       Impact factor: 25.671

7.  Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas.

Authors:  Ivan Damjanov; Peter W Andrews
Journal:  Int J Dev Biol       Date:  2016       Impact factor: 2.203

Review 8.  Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy.

Authors:  Gopika G Nair; Emmanuel S Tzanakakis; Matthias Hebrok
Journal:  Nat Rev Endocrinol       Date:  2020-06-25       Impact factor: 47.564

9.  Shifting gears from embryonic to very small embryonic-like stem cells for regenerative medicine.

Authors:  Deepa Bhartiya
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

10.  Stem cells and beta cell replacement therapy: a prospective health technology assessment study.

Authors:  Klemens Wallner; Rene G Pedroza; Isaac Awotwe; James M Piret; Peter A Senior; A M James Shapiro; Christopher McCabe
Journal:  BMC Endocr Disord       Date:  2018-01-30       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.